Feature
Open Data Campaign
Tamiflu: the battle for secret drug data
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7303 (Published 29 October 2012) Cite this as: BMJ 2012;345:e7303Related articles
- Observations Published: 29 October 2012; BMJ 345 doi:10.1136/bmj.e7305
- Analysis Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5164
- Editorial Published: 29 October 2012; BMJ 345 doi:10.1136/bmj.e7304
- News Published: 23 October 2012; BMJ 345 doi:10.1136/bmj.e7168
- Feature Published: 04 June 2010; BMJ 340 doi:10.1136/bmj.c2912
- Editor's Choice Published: 31 October 2012; BMJ 345 doi:10.1136/bmj.e7332
- News Published: 27 December 2012; BMJ 345 doi:10.1136/bmj.e8684
- Letter Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5374
Tamiflu open data campaignOpen data campaign
See more
- Delays in dealing with complaints against drug companies are growing, BMJ findsBMJ February 14, 2024, 384 q365; DOI: https://doi.org/10.1136/bmj.q365
- Lax oversight of semaglutide advertising could harm patients, warn criticsBMJ December 13, 2023, 383 p2919; DOI: https://doi.org/10.1136/bmj.p2919
- Concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trialBMJ November 15, 2023, 383 p2620; DOI: https://doi.org/10.1136/bmj.p2620
- Trusts are accused of using foreign doctors as “cheap labour” in fellowship schemesBMJ October 25, 2023, 383 p2427; DOI: https://doi.org/10.1136/bmj.p2427
- The US quietly terminates a controversial $125m wildlife virus hunting programme amid safety fearsBMJ September 07, 2023, 382 p2002; DOI: https://doi.org/10.1136/bmj.p2002